Press centre

Latest

26 Mar 2021
Thailand Activates First Site in Global Phase 3 Clinical Study of Zoliflodacin as a New Gonorrhoea Treatment
GARDP and Entasis Therapeutics announced today the activation of the first site in Thailand as part of a global phase 3 clinical study of zoliflodacin for the treatment of gonorrhoea.
Read more